Listed by the USPTO as CHO, DAVID H
Tech Center 1600 • Art Units: 1693
This examiner grants 32% of resolved cases
David H. Cho has 47 resolved cases in Art Unit 1693 of Tech Center 1600. His allowance rate of 31.9 percent is a metric for securing a patent grant. Furthermore, the median days to allowance of 1248 suggests a prosecution process for successful applications, requiring applicants to prepare for the timeline. This duration indicates that achieving a grant in this docket involves a long-term strategy and persistent effort.
The most notable figure is the interview lift of 67.0 percent, which is a data point in this profile. This suggests that conducting an interview is a critical strategy for overcoming rejections and moving toward the 31.9 percent allowance rate. Major applicants such as DSM IP Assets B.V., UNIVERSIDAD DE SEVILLA, and University of Southern California may find this approach a tool for success. Firms like FINNEGAN, HENDERSON, FARABOW, GARRETT & DUNNER, Fox Rothschild LLP, and Knobbe, Martens, Olson & Bear, LLP frequently manage these cases, utilizing the 67.0 percent lift to navigate the examination landscape.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18554922 | NOVEL USE | Final Rejection | DSM IP ASSETS B.V. |
| 18546264 | METHODS FOR REDUCING PATHOGENIC E COLI BY SELECTIVE FEED ADDITIVE INTERVENTION | Non-Final OA | DSM IP Assets B.V. |
| 18088628 | COMPOUND, SOLID CARRIER INCLUDING THE SAME AND METHOD FOR PREPARING NUCLEIC ACID | Final Rejection | Industrial Technology Research Institute |
| 18720268 | COMPOSITIONS FOR PREVENTING OR FOR REDUCING RISK OF DEVELOPING SECONDARY INFECTIOUS DISEASES | Non-Final OA | MEIJI CO., LTD. |
| 18702858 | OLIGOSACCHARIDE COMPLEXES AND USES | Non-Final OA | Universidad de Sevilla |
| 18702863 | OLIGOSACCHARIDE COMPOUNDS AND COMPLEXES | Non-Final OA | Universidad de Sevilla |
| 18705643 | 3D PRINTING SUPPORT MATERIAL AND METHOD FOR MANUFACTURING SAME | Non-Final OA | OSAKA UNIVERSITY |
| 18300468 | PHARMACOLOGIC APPROACH FOR SUPPRESSION OF CORONAVIRUSES | Final Rejection | Temple University - of the Commonwealth System of Higher Education |
| 18020880 | FORMULATIONS OF NICOTINIC ACID DERIVATIVES AND FLAVONOID POLYPHENOLS AND USES THEREOF | Final Rejection | Animal Biosciences, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy31.9% of resolved applications examined by David H Cho were allowed (47 resolved cases), compared with 59.4% across Art Unit 1693 over the last five years.
This examiner's interview lift is +67.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by David H Cho took 1,248 days on average from filing to allowance.
David H Cho examines applications in Art Unit 1693 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
